We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · March 18, 2021

Cerliponase Alfa Changes the Natural History of Children With CLN2

European Journal of Paediatric Neurology

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Paediatric Neurology
Cerliponase Alfa Changes the Natural History of Children With Neuronal Ceroid Lipofuscinosis Type 2: The First French Cohort
Eur. J. Paediatr. Neurol. 2020 Dec 08;[EPub Ahead of Print], B Estublier, A Cano, C Hoebeke, S Pichard, D Scavarda, I Desguerre, S Auvin, B Chabrol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading